Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 506260 | NSE Symbol : ANUHPHR | ISIN : INE489G01022 | Industry : Pharmaceuticals - Indian - Bulk Drugs |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
31-Jan-2025	07-Feb-2025	Quarterly Results	ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve unaudited financial results for the quarter ended 31st December 2024 and to consider any other matter with the permission of the Chairman. To consider and approve the Un-audited Financial Results and Limited Review Report for the Quarter ended 31st December, 2024. (As per BSE Announcement Dated on 07/02/2025)
29-Oct-2024	08-Nov-2024	Quarterly Results	Quarterly Results To consider and approve the Un-audited Financial results and Limited Review Report for the Quarter and half year ended 30th September, 2024 and approving the revised Policy for Prevention of Sexual Harassment (POSH) at Workplace as per The Sexual Harassment of Women at Workplace (Prevention, Prohibition and; Redressal) Act, 2013 ('Act'). (As per BSE Announcement Dated on 08/11/2024)
02-Aug-2024	09-Aug-2024	Quarterly Results	ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve Unaudited financial results for the quarter ended 30th June 2024 and to consider any other matter with the permission of the Chairman. To consider and approve the Un-audited Financial results and Limited Review Report for the Quarter ended 30th June, 2024 (As per BSE Announcement Dated on 09/08/2024)
09-May-2024	17-May-2024	Final Dividend	ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 inter alia to consider and approve Audited Financial Results for the Quarter and Financial Year ended 31st March 2024 and recommendation of Final Dividend if any for the Financial Year 2023-24. TO consider and approve the Audited Financial Results for the Financial Year ending 31st March, 2024, recommendation of Dividend for the Financial Year, 2023-24 and Fixation the date of AGM pf the Company. Results for Financial year ended 31st March, 2024 (As per BSE Announcement Dated on 17/05/2024)
04-Apr-2024	04-Apr-2024	Change in Other Executives	To consider and approve the following agendas: 1. Appointment of Mr. Manan Jayesh Vadhan as Company Secretary and Compliance Officer of the Company w.e.f. 04th April, 2024. 2. Approval on investment in Huoban Energy 5 Private Limited (SPV) for 'Solar Project', under group captive model under open access Appointment of Company Secretary and Compliance Officer (As Per BSE Announcement dated on 04.04.2024)
01-Feb-2024	09-Feb-2024	Quarterly Results	ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve Unaudited Financial Results for the quarter ended 31.12.2023 To consider and approve the Un-audited Financial Results for the quarter and nine months ended 31.12.2023 (As per BSE Announcement Dated on 09/02/2024)
05-Jan-2024	05-Jan-2024	Change in Other Executives	Appointment of Ms. Jinal Ajay Shah as the Company Secretary & Compliance Officer and designated her as a Key Managerial Personnel of the Company w.e.f. January 15, 2024. Appointment of Company Secretary and Compliance Officer.
02-Nov-2023	10-Nov-2023	Quarterly Results	ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve 1) To consider and approve Unaudited Financial Results of the Company for the quarter ended 30th September 2023; and 2) To the approval of Postal Ballot Notice. Outcome of Board Meeting dated 10th November, 2023 (As Per BSE Announcement Dated on 10.11.2023)
03-Aug-2023	11-Aug-2023	Quarterly Results	ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve 1) To consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June 2023; and 2) To consider any other matter with the permission of the Chairman. Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the Board of Directors of the Company (the 'Board') at its Meeting held today i.e. Friday, 11th August, 2023, inter-alia considered and approved the following agenda Items: 1. The Un-Audited Financial Results along with Limited Review Report thereon for the quarter ended 30th June, 2023. (As Per BSE Announcement Dated on 11.08.2023)
11-May-2023	19-May-2023	Accounts	ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2023 inter alia to consider and approve 1) To consider and approve Audited Financial Results of the Company for the quarter & year ended 31st March 2023; and 2) To consider and recommend Final Dividend if any for the Financial Year 2022-23. Outcome of Board Meeting dated 19th May, 2023 Results-Financial Results for March 31, 2023. (As Per BSE Announcement dated on 19.05.2023) Intimation under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Change in Director. (As Per BSE Announcement Dated on 20/05/2023)
03-Feb-2023	10-Feb-2023	Quarterly Results	ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 inter alia to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday 10th February 2023 inter alia: 1) To consider and approve Unaudited Financial Results of the Company for the quarter ended 31st December 2022; and 2) To consider any other matter with the permission of the Chairman. Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are enclosing herewith the following: 1. Unaudited Financial Results for the quarter ended December 31, 2022; and 2. Limited Review Report for the quarter ended December 31, 2022. You are requested to kindly take the same on record. Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the Board of Directors of the Company (the 'Board') at its Meeting held today i.e. Friday, 10th February, 2023, inter-alia considered and approved the following agenda Items: 1. The Un-Audited Financial Results along with Limited Review Report thereon for the quarter ended 31st December, 2022. 2. The Board has approved the Resignation of Mr. Lalitkumar P Shah from the post of Director of Anuh Pharma Limited with immediate effect. The Meeting of the Board of Directors commenced at 12:30 p.m. and concluded at 4:15 p.m (As Per BSE Announcement dated on 10.02.2023)
06-Jan-2023	06-Jan-2023	Change in Other Executives	Outcome of Board Meeting dated 6th January, 2023. Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement dated on 07.01.2023)
29-Oct-2022	07-Nov-2022	Quarterly Results	ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2022 inter alia to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Monday 7th November 2022 inter alia: 1) To consider and approve Unaudited Financial Results of the Company for the quarter ended 30th September 2022; and 2) To consider any other matter with the permission of the Chairman. Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the Board of Directors of the Company (the 'Board') at its Meeting held today i.e. Monday, 7th November, 2022, inter-alia considered and approved the following agenda Items: 1. The Un-audited Financial Results along with Limited Review Report thereon for the quarter ended 30th September, 2022. The Meeting of the Board of Directors commenced at 12:30 PM and concluded at 3:15 PM Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are enclosing herewith the following: 1. Unaudited Financial Results for the quarter ended September 30, 2022; and 2. Limited Review Report for the quarter ended September 30, 2022 (As Per BSE Announcement Dated on 07.11.2022) Dear Sir/Madam, Pursuant to the provisions of Regulation 30 read with Schedule III Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the Board of Directors of the Company (the 'Board') at its Meeting held on Monday, 7th November, 2022, has noted the resignation of Mr. Bharat Gangani, from the post of Company Secretary and Compliance Officer of the Company. Company has already made an intimation regarding the resignation of Mr. Bharat Gangani as a Company Secretary and Compliance Officer to the Stock Exchange on 20th October, 2022. The Meeting of the Board of Directors commenced at 12:30 PM and concluded at 3:15 PM. (As Per BSE Announcement Dated on 08.11.2022)
27-Jul-2022	05-Aug-2022	Quarterly Results	ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2022 inter alia to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday 5th August 2022 inter alia: l) To consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June 2022; and 2) To consider any other matter with the permission of the Chairman. Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company (the 'Board') at its Meeting held today i.e. Friday, 5th August, 2022, inter-alia considered and approved the following agenda Items: 1. The Un-audited Financial Results along with Limited Review Report thereon for the quarter ended 30th June, 2022. Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following: 1. Unaudited Financial Results for the quarter ended June 30, 2022; and 2. Limited Review Report for the quarter ended June 30, 2022. (As per BSE Announcement Dated on 05/08/2022) We would like to inform that the Members of the Company in their meeting held on Friday, August 05, 2022, have considered and approved the request received from few Promoters/ Promoter Group of the Company seeking reclassification of their shareholding from 'Promoters/ Promoter Group' to 'Public' category' (the same was recommended by the Board of Directors at its Meeting held on 14th May, 2022). (As Per BSE Announcement Dated on 06/08/2022)
07-May-2022	14-May-2022	Quarterly Results	ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2022 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Saturday, 14th May, 2022, inter alia: 1) To consider and approve Audited Financial Results of the Company for the quarter & year ended 31st March, 2022; and 2) To consider and recommend Final Dividend, if any, for the financial year 2021-22. Anuh Pharma Ltd. has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 14, 2022, inter alia, to consider and approve the audited financial results for the quarter and year ended March 31, 2022 and to consider recommendation of dividend, if any, amongst other routine matters. (As Per BSE Announcement Dated on 07.05.2022) Anuh Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2022, inter alia has recommended final dividend of Rs. 1.75/- per equity share of face value of Rs. 5/- each (i.e. 35%) for the Financial Year ended March 31, 2022, subject to the approval of the Shareholders at the ensuing Annual General Meeting of the Company. Outcome of Board Meeting held on 14th May 2022 (As Per BSE Announcement dated on 14.05.2022) Please find enclosed herewith the copy of newspaper advertisement with respect to the Audited Financial Results for the quarter and year ended 31' March, 2022, published in the Financial Express and Mumbai Lakshadeep on Sunday, May 15, 2022 in compliance with Regulation 4 7 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement dated on 16.05.2022)

1 2

LOGIN HERE

Anuh Pharma Ltd

Board Meeting